Abeona Therapeutics (ABEO) Interest Expenses (2010 - 2026)

Abeona Therapeutics' Interest Expenses history runs 17 years deep, the most recent figure standing at $1.4 million for Q1 2026.

• On a quarterly basis, Interest Expenses fell 0.51% year-over-year to $1.4 million in Q1 2026; TTM through Mar 2026 was $1.4 million, a 0.51% decrease from a year earlier, with the FY2025 full-year figure at $74.9 million, up 1680.47% from the prior year.
• Interest Expenses advanced to $1.4 million in Q1 2026 per ABEO's latest filing, from -$988000.0 in the prior quarter.
• Across five years, Interest Expenses topped out at $11.5 million in Q1 2022 and bottomed at -$988000.0 in Q4 2025.
• The 5-year median for Interest Expenses is $1.4 million (2023), against an average of $2.9 million.
• Across the five-year window, Interest Expenses surged 892.66% in 2024 and tumbled 191.31% in 2025, its largest moves.
• Year by year, Interest Expenses stood at $178000.0 in 2022, then slumped by 38.76% to $109000.0 in 2023, then jumped by 892.66% to $1.1 million in 2024, then tumbled by 191.31% to -$988000.0 in 2025, then surged by 237.35% to $1.4 million in 2026.
• Per Business Quant, the three latest ABEO Interest Expenses figures stand at $1.4 million (Q1 2026), -$988000.0 (Q4 2025), and $1.4 million (Q3 2025).